{"id":"W2025005625","doi":"10.1016/j.beha.2013.07.007","title":"Novel oral anticoagulants in secondary prevention of stroke","year":2013,"lang":"en","type":"review","venue":"Best Practice & Research Clinical Haematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"ca_institutions":"Population Health Research Institute; McMaster University","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; Novartis; Bristol-Myers Squibb","keywords":"Apixaban; Medicine; Rivaroxaban; Warfarin; Dabigatran; Atrial fibrillation; Aspirin; Stroke (engine); Direct thrombin inhibitor; Phenprocoumon; Discovery and development of direct thrombin inhibitors; Internal medicine; Thrombin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009313617,0.0008237793,0.003253688,0.002731886,0.0002265523,0.001068873,0.001101585,0.00122604,0.004695539],"category_scores_gemma":[0.002273383,0.0004348323,0.001603493,0.002165748,0.000349822,0.001033305,0.000542063,0.001611455,0.0007866421],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004286524,"about_ca_system_score_gemma":0.001039509,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001523301,"about_ca_topic_score_gemma":0.003319485,"domain_scores_codex":[0.999563,0.00007050936,0.000140549,0.00006572896,0.000133176,0.00002683496],"domain_scores_gemma":[0.9989281,0.0006811119,0.0002160044,0.00001806362,0.0001241521,0.00003251585],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003109584,0.0001273442,0.000501266,0.06671145,0.001414064,0.0003139493,0.00005512983,0.0002419101,0.0006403793,0.001070853,0.01208935,0.9165233],"study_design_scores_gemma":[0.001907018,0.001307998,0.01057033,0.1032941,0.02112203,0.007814893,0.0003297745,0.001018297,0.001688093,0.00579196,0.8449944,0.0001611053],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000132633,0.999375,0.00006015416,0.00008021882,0.00007794087,0.000006021951,0.00001181614,0.000003570158,0.0002526469],"genre_scores_gemma":[0.001312668,0.9980425,0.0002016066,0.0001363745,0.0001463757,0.000007946404,0.00002253728,9.460319e-7,0.0001291085],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004695539,"threshold_uncertainty_score":0.01570815,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.6486534242812891,"score_gpt":0.6463741036705688,"score_spread":0.002279320610720337,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}